Champions Oncology Inc. (CSBR)
Champions Oncology Statistics
Share Statistics
Champions Oncology has 13.83M shares outstanding. The number of shares has increased by 1.71% in one year.
| 13.83M |
| 1.71% |
| 0.06% |
| 42.07% |
| n/a |
| 8 |
| 0.02% |
Short Selling Information
The latest short interest is 106.43K, so 0.77% of the outstanding shares have been sold short.
| 106.43K |
| 0.77% |
| 1.86% |
| 2.38 |
Valuation Ratios
The PE ratio is -9.03 and the forward PE ratio is 29.14. Champions Oncology's PEG ratio is -0.23.
| -9.03 |
| 29.14 |
| 1.31 |
| 1.2 |
| -34.53 |
| -9.42 |
| -0.23 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Champions Oncology.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 0.63, with a Debt / Equity ratio of -3.9.
| 0.63 |
| 0.63 |
| -3.9 |
| -1.47 |
| -1.07 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $238,833.33 |
| $-34,647.62 |
| 210 |
| 1.92 |
| n/a |
Taxes
| -32K |
| 0.44% |
Stock Price Statistics
The stock price has increased by 39.14% in the last 52 weeks. The beta is 0.37, so Champions Oncology's price volatility has been higher than the market average.
| 0.37 |
| 39.14% |
| 7.1 |
| 6.92 |
| 51.02 |
| 37,788 |
Income Statement
In the last 12 months, Champions Oncology had revenue of 50.16M and earned -7.28M in profits. Earnings per share was -0.54.
| 50.16M |
| 20.75M |
| -7.36M |
| -7.28M |
| -5.05M |
| -6.92M |
| -0.54 |
Balance Sheet
The company has 2.62M in cash and 7.43M in debt, giving a net cash position of -4.81M.
| 2.62M |
| 7.43M |
| -4.81M |
| -84.59M |
| 30.63M |
| -173K |
Cash Flow
In the last 12 months, operating cash flow was -6.14M and capital expenditures -836K, giving a free cash flow of -6.97M.
| -6.14M |
| -836K |
| -6.97M |
| -0.51 |
Margins
Gross margin is 41.38%, with operating and profit margins of -14.67% and -14.51%.
| 41.38% |
| -14.67% |
| -14.57% |
| -14.51% |
| -10.08% |
| -14.67% |
| -13.9% |
Dividends & Yields
CSBR does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for CSBR is $12, which is 85.5% higher than the current price. The consensus rating is "Strong Buy".
| $12 |
| 85.5% |
| Strong Buy |
| 1 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Aug 12, 2015. It was a backward split with a ratio of 1:12.
| Aug 12, 2015 |
| backward |
| 1:12 |
Scores
| 4.6 |
| 5 |